PAROLINI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 5.779
AS - Asia 3.215
EU - Europa 2.828
SA - Sud America 427
AF - Africa 65
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 7
Totale 12.339
Nazione #
US - Stati Uniti d'America 5.689
CN - Cina 1.430
SG - Singapore 879
PL - Polonia 761
UA - Ucraina 534
BR - Brasile 363
IT - Italia 359
DE - Germania 281
HK - Hong Kong 257
FR - Francia 209
FI - Finlandia 201
IN - India 168
VN - Vietnam 166
GB - Regno Unito 163
TR - Turchia 93
IE - Irlanda 89
RU - Federazione Russa 81
CA - Canada 55
BD - Bangladesh 51
SE - Svezia 38
AR - Argentina 27
KR - Corea 26
BE - Belgio 23
IQ - Iraq 22
MX - Messico 19
NL - Olanda 19
ZA - Sudafrica 19
AU - Australia 18
JP - Giappone 18
ID - Indonesia 17
ES - Italia 15
MA - Marocco 13
CZ - Repubblica Ceca 11
AT - Austria 10
CO - Colombia 10
EC - Ecuador 10
NG - Nigeria 10
PK - Pakistan 10
SA - Arabia Saudita 10
UZ - Uzbekistan 9
KZ - Kazakistan 8
LT - Lituania 8
MU - Mauritius 7
AZ - Azerbaigian 6
EU - Europa 6
LB - Libano 6
PH - Filippine 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
CL - Cile 5
KE - Kenya 5
GR - Grecia 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
RO - Romania 4
TT - Trinidad e Tobago 4
VE - Venezuela 4
CH - Svizzera 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HN - Honduras 3
IL - Israele 3
LV - Lettonia 3
AM - Armenia 2
BH - Bahrain 2
DK - Danimarca 2
EG - Egitto 2
NP - Nepal 2
OM - Oman 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BB - Barbados 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CY - Cipro 1
EE - Estonia 1
ET - Etiopia 1
GT - Guatemala 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LS - Lesotho 1
LU - Lussemburgo 1
MD - Moldavia 1
MK - Macedonia 1
ML - Mali 1
MN - Mongolia 1
NO - Norvegia 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TJ - Tagikistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 12.339
Città #
Warsaw 760
Fairfield 640
Ashburn 515
Singapore 487
Woodbridge 452
Shenzhen 406
Jacksonville 371
Houston 357
Chandler 296
Cambridge 278
Ann Arbor 269
Hong Kong 254
Seattle 246
Wilmington 229
Beijing 203
San Jose 191
Brescia 153
Nanjing 152
Princeton 152
New York 143
The Dalles 133
Los Angeles 121
Helsinki 107
Dearborn 87
Dublin 87
Lauterbourg 78
Istanbul 63
Nanchang 57
Buffalo 55
Dallas 55
Ho Chi Minh City 50
Munich 48
Changsha 39
Jinan 39
Milan 38
Moscow 36
San Diego 35
Des Moines 34
Shenyang 34
São Paulo 33
Council Bluffs 31
London 31
Tianjin 30
Chicago 29
Hanoi 29
San Francisco 28
Hebei 27
Redondo Beach 25
Shanghai 25
Turku 25
Santa Clara 24
Brussels 20
Dong Ket 20
Montreal 20
Orem 20
Seongnam 19
Toronto 18
Tokyo 17
Verona 16
Zhengzhou 16
Brooklyn 15
Jiaxing 15
Kocaeli 15
Hangzhou 14
Rio de Janeiro 14
Stockholm 14
Genova 13
Indianapolis 13
Kunming 13
Phoenix 13
Charlotte 12
Chennai 12
Jakarta 12
Johannesburg 12
Ningbo 12
Augusta 11
Denver 11
Taizhou 11
Abuja 10
Changchun 10
Frankfurt am Main 10
Manchester 10
Mexico City 10
Amsterdam 9
Atlanta 9
Boardman 9
Brasília 9
Haikou 9
Lanzhou 9
Leawood 9
Rome 9
Tashkent 9
Washington 9
Brno 8
Haiphong 8
Mumbai 8
Poplar 8
Lancaster 7
Lappeenranta 7
Origgio 7
Totale 8.678
Nome #
Occurrence of nodular lymphocyte-predominant hodgkin lymphoma in hermansky-pudlak type 2 syndrome is associated to natural killer and natural killer T cell defects. 577
A novel primary human immunodeficiency due to deficiency in the WASP-interacting protein WIP 388
Impaired natural killer cell functions in patients with signal transducer and activator of transcription 1 (STAT1) gain-of-function mutations 384
NFKB1 regulates human NK cell maturation and effector functions 341
Identification of a subset of human natural killer cells expressing high levels of programmed death 1: A phenotypic and functional characterization 297
XLP1 inhibitory effect by 2B4 does not affect DNAM-1 and NKG2D activating pathways in NK cells. 296
B7-H6-mediated downregulation of NKp30 in NK cells contributes to ovarian carcinoma immune escape 232
Clinical, laboratory and molecular signs of immunodeficiency in patients with partial oculo-cutaneous albinism. 221
CTLA-4 regulates human Natural Killer cell effector functions 211
The RAC2-PI3K axis regulates human NK cell maturation and function 208
Defective natural killer-cell cytotoxic activity in NFKB2-mutated CVID-like disease 205
Activin A as a Mediator of NK-Dendritic Cell Functional Interactions. 198
Basic fibroblast growth factor-induced angiogenic phenotype in mouse endothelium. A study of aortic and microvascular endothelial cell lines. 196
A monoallelic activating mutation in RAC2 resulting in a combined immunodeficiency 194
Functional Characterization Of Natural Killer Cells In Type I Leukocyte Adhesion Deficiency 189
Effects of opioid therapy on human natural killer cells. 188
Biological characterization and in vitro effects of human concentrated growth factor preparation: An innovative approach to tissue regeneration 185
Inherited DOCK2 deficiency in patients with early-onset invasive infections 185
2B4 functions as a co-receptor in human NK cell activation 167
Upregulation of urokinase-type plasminogen activator in squamous cell carcinoma of human larynx 167
Cellular and molecular pathogenesis of X-linked lymphoproliferative disease. 155
Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content. 155
Strengthening the AntiTumor NK Cell Function for the Treatment of Ovarian Cancer. 154
Selective cross-talk among natural cytotoxicity receptors in human natural killer cells 153
Primitive neuroectodermal tumor in an ovarian cystic teratoma: natural killer and neuroblastoma cell analysis 152
Diagnosing XLP1 in patients with hemophagocytic lymphohistiocytosis. 149
NK cells at the interface between innate and adaptive immunity 142
Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. 141
X-linked lymphoproliferative disease: the dark side of 2B4 function. 141
Novel insights from adaptor protein 3 complex deficiency 139
Reduced thymic output, increased spontaneous apoptosis and oligoclonal B cells in polyethylene glycol-adenosine deaminase-treated patients 138
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases 137
From Natural Killer Cell Receptor Discovery to Characterization of Natural Killer Cell Defects in Primary Immunodeficiencies 137
Exome sequencing reveals a pallidin mutation in a Hermansky-Pudlak-like primary immunodeficiency syndrome 136
CD59 is physically and functionally associated to Natural Citotoxicity Receptors and activates human NK cell mediated cytotoxicity. 133
Basement Membrane Components in Normal, Dysplastic and Neoplastic Epithelia of the Uterine Cervix 133
The role of chemerin in the co-localization of NK and dendritic cell subsets into inflamed tissues. 133
Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors 133
Involvement of natural cytotoxicity receptors in human natural killer cell-mediated lysis of neuroblastoma and glioblastoma cell lines 132
Innate immunity defects in Hermansky-Pudlak type 2 syndrome 131
Pseudorabies virus US3 protein kinase protects infected cells from NK cell-mediated lysis via increased binding of the inhibitory NK cell receptor CD300a 131
La sindrome emofagocitica: dai sintomi alle cause genetiche 130
Severe impairment of IFN-γ and IFN-α responses in cells of a patient with a novel STAT1 splicing mutation. 130
GPR56 as a novel marker identifying the CD56dull CD16+ Nk cell subset both in blood stream and in inflamed peripheral tissues 129
Human natural killer cell receptors and co-receptors 128
NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily. 128
Natural killer cell hyporesponsiveness and impaired development in a CD247-deficient patient 128
Identification of NKp80, a novel triggering molecule expressed by human NK cells 126
Development of chicken embryos exposed to an intermittent horizontal sinusoidal 50 Hz magnetic field. 125
[Distribution of laminin, type IV collagen and fibronectin in normal, dysplastic and neoplastic laryngeal tissue]. 125
Combined immunodeficiency with autoimmunity caused by a homozygous missense mutation in inhibitor of nuclear factor κB kinase alpha (IKKα) 121
NK cells and their receptors during viral infections. 120
CD94 functions as a natural killer cells inhibitory receptor for different HLA class I alleles: identification of the inhibitory form of CD94 by the use of novel monoclonal antibodies. 117
CARD11 dominant negative mutation leads to altered human Natural Killer cell homeostasis 116
Response to the Letter to the Editor Regarding “Functional evaluation of natural killer cell cytotoxic activity in NFKB-2 mutated patients” 114
Characterization of a new patient with STAT1 deficiency: new insights into IFNs signal transduction pathways 113
P85α is an intrinsic regulator of human natural killer cell effector functions 113
IL21 induces both rapid maturation of human CD34+ cell precursors towards NK cell and acquisition of surface killer Ig-like receptors 112
Identification and Molecular Characterization of NKp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells. 110
The AZ158 mAb specifically reacts with p70 and p140 inhibitory NK receptors for HLA-B and HLA-A alleles 108
Exome Sequencing Reveals a Pallidin Mutation in a Hermansky-Pudlak-Like Primary Immunodeficiency Syndrome 107
Function and specificity of human natural killer cell receptors. 107
X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein-Barr virus-infected cells 107
The LIR-1 receptor for the cytomegalovirus UL18 protein displays a broad specificity for different HLA class I alleles. 102
Triggering Receptors involved in Natural Killer cell mediated cytotoxicity against Choriocarcinomas cells lines 101
IL-12 or IL-4 Prime Human NK Cells to Mediate Functionally Divergent Interaction with Cells or Tumors 100
In vitro treatment with concentrated growth factors (CGF) and sodium orthosilicate positively affects cell renewal in three different human cell lines 100
Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications 99
Distinctive Lack of CD48 Expression in Subsets of Human Dendritic Cells Tunes Natural Killer Cell Activation 98
Natural killer cell impairment in ovarian clear cell carcinoma 98
Linker for Activation of T cells (LAT), a novel immunohistochemical marker for T cells, NK cells, mast cells, and megakaryocytes. Evaluation in normal and pathological conditions 97
Growth advantage and vascularization induced by basic fibroblast growth factor overexpression in endometrial HEC-1-B cells: an export-dependent mechanism of action. 97
Killer cell immunoglobulin-like receptor expression delineates in situ Sezary syndrome lymphocytes 96
FGF-trapping hampers cancer stem-like cells in uveal melanoma 94
Immunohistochemical localization of laminin, collagen IV and fibronectin in dysplasias and neoplasms of the cervix uteri 94
Inhibitory CD94 molecules identified by the Z199 monoclonal antibody recognize different HLA-class I molecules. 94
Immunocytochemical localization of plasminogen activators in carcinomas in the cervix and vulva. 88
Lack of iNKT Cells and Defects on Differentiation of Dendritic Cells in Patients with Hermansky-Pudlak Type 2 Syndrome (HPS2) 88
Impaired natural and CD16-mediated NK cell cytotoxic function in WAS and XLT patients: ability of IL-2 to correct NK cell functional defect 86
Distribuzione di laminina, collagene di tipo IV e fibronectina nel tessuto laringeo normale, displastico e neoplastico. 83
Lack of DOCK8 impairs the primary biologic functions of human NK cells and abrogates CCR7 surface expression in a WASP-independent manner 82
LAT (Linker for activation of T cells): A novel immunohistochemical marker for T, NK, mast cells and megakaryocytes. Evaluation in normal and pathological conditions. 77
NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of Natutal Killer cells to kill Epstein-Barr virus-infected B cells in X-linked lymphoproliferative disease 74
The novel XIAP Lys396Ter variant alters mitochondrial membrane potential and endoplasmic reticulum intensity in monocytes of two XIAP-deficient patients. 32
PD-1+ NK cell subsets in high grade serous ovarian cancer: an indicator of disease severity and a target for combined immunecheckpoint blockade 30
Integrating interferon gamma receptor pathways, antigenicity, and immune contexture as predictors of immunotherapeutic strategies for mucosal melanomas 21
Totale 12.529
Categoria #
all - tutte 54.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 54.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202150 0 0 0 0 0 0 0 0 0 0 0 50
2021/2022768 45 146 15 52 16 26 30 42 48 106 53 189
2022/2023787 120 7 14 93 55 216 7 88 105 7 37 38
2023/20241.022 43 10 469 30 28 131 38 44 128 4 9 88
2024/20251.368 13 4 9 187 164 113 112 68 165 75 285 173
2025/20262.974 280 366 277 410 302 198 427 137 204 221 86 66
Totale 12.529